Q2 2025 Earnings Call Transcript August 1, 2025 Moderna, Inc. beats earnings expectations. Reported EPS is $-2.13, ...

U.S. health officials have told more than a half-dozen of the nation’s top medical organizations that they will no longer ...

Moderna Inc. (NASDAQ:MRNA) reported on Friday a second-quarter loss of $2.13 per share, beating the consensus of a $2.98 loss ...

The layoffs are part of an ongoing effort to reduce operating costs amid government and competitive challenges to its vaccine ...

(NASDAQ:MRNA) today reported financial results and provided business updates for the second quarter of 2025. "In the last three months, we advanced our pipeline with positive Phase 3 flu vaccine ...

WASHINGTON, DC – Dr. Vinay Prasad, the polarizing official who led U.S. vaccine oversight under the Trump administration, has ...

New study reveals that the stereochemistry of lipid nanoparticles critically influences safety and efficacy in mRNA delivery.

“Midlife women often juggle caregiving, careers, and hormonal shifts that can strain the immune system,” Boden-Albala says.

It is hard to imagine someone more equipped and more dedicated to vetting treatments than Vinay Prasad,” writes his former ...

As federal vaccine policy shifts under US health secretary Robert F. Kennedy Jr., lawmakers are looking to give state-level ...

In the last decade, the percentage of kindergartners with medical exemptions has held steady, at about 0.2%. But the ...

In their zeal to “Make America Healthy Again,” Trump administration officials are making statements that some advocacy and ...